Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
University of Wisconsin, Madison · with National Institute on Aging (NIA) · NCT07812337
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 50+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 70
- US sites recruiting
- 1
- Study start
- October 1, 2026
- Record last updated
- October 5, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of the current study is to evaluate a decision-support tool intended to help primary care providers (PCPs) communicate with patients about blood biomarker testing for Alzheimer's Disease, enhancing shared-decision making and information sharing in the clinical space. The main questions it aims to answer are:
- Is the decision-support tool accepted and easy to use for PCPs?
- Does using the tool improve shared decision-making during clinical encounters? Researchers will compare clinical encounters between PCPs who do not use the tool to discuss blood biomarker testing for Alzheimer's Disease, versus PCPs who have been trained to utilize the tool during clinical encounters to see whether the tool effectively facilitates shared-decision making.
Being studied: Shared decision-making support tool
Conditions: Cognitive Abnormality
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Simulation 1 and Simulation 2: PCPs with experience and interest in cognitive diagnosis.
- Simulation 2: community dwelling older adults age 50 or older are eligible.
Exclusion Criteria (PCP): none
Participant Exclusion Criteria
- Not fluent in English
- age \<50 years
- pre-existing diagnosis of cognitive impairment
- having an activated medical decision-make r or not living independently in the community.
There will be no exclusion based upon sex/gender, race, or ethnicity.
Recruiting US locations
School of Medicine and Public Health, University of Wisconsin
Madison, WI 53705
Site contact: Fred Ketchum, M.D., PhD · 608-265-5523 · fketchum@wisc.edu
Study contacts (from the official record)
- Fred Ketchum, M.D., Ph.D. · 608-265-5523 · BiomarkersInPrimarycare@neurology.wisc.edu
Similar studies in Wisconsin
All neurology studies in Wisconsin →- RecruitingHealthy volunteersPhase 1
The Gut - PRO Study
University of Wisconsin, Madison
- Location
- Madison, WI
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Milwaukee, WI + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Greenfield, WI + 17 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Milwaukee, WI + 18 other US sites
- Eligibility basics
- Ages 18–60